Biomolecules · 2019 · 12 citations · 18 references
MedicineOncologyPharmacologyApoptosisChemotherapyInflammationAnti-inflammatory PharmacologyApoptosis PharmacologyColorectal CancerGastrointestinal InflammationInflammation PharmacologyInflammatory Bowel DiseaseCancer Cell ApoptosisCell Cycle InhibitionCell Death AssaysCell Viability AssaysColorectal Carcinogenesis PathophysiologyInflammatory Bowel Disease PathophysiologyInflammatory Bowel Disease Therapy
Inflammatory bowel disease (IBD) is general term for ulcerative colitis and Crohn’s disease, which is chronic intestinal and colorectal inflammation caused by microbial infiltration or immunocyte attack. IBD is not curable, and is highly susceptible to develop into colorectal cancer. Finding agents to alleviate these symptoms, as well as any progression of IBD, is a critical effort. This study evaluates the anti-inflammation and anti-tumor activity of 16-hydroxycleroda-3,13-dien-15,16-olide (HCD) in in vivo and in vitro assays. The result of an IBD mouse model induced using intraperitoneal chemical azoxymethane (AOM)/dextran sodium sulfate (DSS) injection showed that intraperitoneal HCD adminstration could ameliorate the inflammatory symptoms of IBD mice. In the in vitro assay, cytotoxic characteristics and retained signaling pathways of HCD treatment were analyzed by MTT assay, cell cycle analysis, and Western blotting. From cell viability determination, the IC50 of HCD in Caco-2 was significantly lower in 2.30 μM at 48 h when compared to 5-fluorouracil (5-FU) (66.79 μM). By cell cycle and Western blotting analysis, the cell death characteristics of HCD treatment in Caco-2 exhibited the involvement of extrinsic and intrinsic pathways in cell death, for which intrinsic apoptosis was predominantly activated via the reduction in growth factor signaling. These potential treatments against colon cancer demonstrate that HCD could provide a promising adjuvant as an alternative medicine in combating colorectal cancer and IBD.
18
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed, Peter W. Eide, Ina A. Eilertsen et al. · Oncogenesis · 2013 · 906 citations · Full text
AOM/DSS Model of Colitis-Associated Cancer
Bobak Parang, Caitlyn W. Barrett, Christopher S. Williams · Methods in molecular biology · 2016 · 273 citations · Full text
Medicine, Immunology, Oncology +14
Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease−Associated Colorectal Cancers
Ana I. Robles, Giovanni Traverso, Ming Zhang et al. · Gastroenterology · 2016 · 268 citations · Full text
p53 Mediates TNF-Induced Epithelial Cell Apoptosis in IBD
Tatiana Goretsky, Ramanarao Dirisina, Preetika Sinh et al. · American Journal Of Pathology · 2012 · 103 citations · Full text